Skip to main content

Table 1 Differentially expressed miRNAs in BN and BC.

From: Identification and analysis of miRNAs in human breast cancer and teratoma samples using deep sequencing

miRNA BN BC Fold change
mir-200b 22.8 (1) 27122.2 (2325) 1189.6
mir-200c 45.5 (2) 44072.2 (3778) 968.6
mir-21 22.8 (1) 15363.4 (1317) 673.8
mir-378 68944.3 (3027) 466.6 (40) -147.8
let-7a 2186.5 (96) 50313.2 (4313) 23.0
mir-320 136180.4 (5979) 19376.4 (1661) -7.0
mir-23a 11319.9 (497) 44748.8 (3836) 4.0
mir-22 25646.3 (1126) 7150.9 (613) -3.6
  1. MiRNAs significantly differentially expressed in normal breast (BN) and breast cancer (BC) samples, with False Discovery Rate of 0.05. Columns show the miRNA id, the observed expression in BN and BC as parts-per-million (ppm) and raw read counts in parentheses, and the relative fold change. The ppm values were based on the total number of 19 – 24 nt long reads in each library. Five miRNAs were found to be overexpressed in BC compared to BN (positive fold change), while three were underexpressed (negative fold change).